AAD 2026Abstract 75107
Impact of Optimal vs Moderate Skin and Itch Treatment Targets on Patient-Reported Outcomes in Moderate-to-Severe Atopic Dermatitis
Insights from Measure Up 1 and 2 Phase 3 Studies
Kirchhof MG, Bunick CG, Savage LJ, Ruiz Dasilva D, Staubach P, Oishi TS, Prefontaine D, Li C, Truong B, Calimlim B, Silverberg JI
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczemaItch & prurigo
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1041 · Not in PubMed: details from Crossref